Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.
about
Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east ScotlandIntractable and highly active relapsing multiple sclerosis - role of alemtuzumabThe role of neurotrophins in multiple sclerosis-pathological and clinical implicationsOutcome Measures in Clinical Trials for Multiple Sclerosis.The natural history of multiple sclerosis: a regional study with some longitudinal data.Multiple sclerosis, tropical spastic paraparesis and HTLV-1 infection in Afro-Caribbean patients in the United Kingdom.Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.An immunogenetic heterogeneity in multiple sclerosis.A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effectsOnset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.Multiple sclerosis: mortality in Scotland 1974-80Multiple sclerosis: it epidemiological, genetic, and health care impactCharacteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US surveyBenign form of multiple sclerosis: MRI evidence for less frequent and less inflammatory disease activity.Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical eventsPrognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway.Is the frequency of multiple sclerosis increasing in Mexico?Environmental factors and multiple sclerosis severity: a descriptive study.The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disabilityHigh-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Aggressive multiple sclerosis: proposed definition and treatment algorithm.MS Prevalence and Patients' Characteristics in the District of Braga, PortugalRelapses and disability accumulation in progressive multiple sclerosisMultiple sclerosis and palliative care - perceptions of severely affected multiple sclerosis patients and their health professionals: a qualitative study.Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.Age and disability accumulation in multiple sclerosis.Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.Randomised, double blind, placebo controlled study of interferon beta-1a in relapsing-remitting multiple sclerosis analysed by area under disability/time curvesPrevalence of multiple sclerosis in the L'Aquila district, central Italy.Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis.Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.Mitoxantrone as a potential therapy for primary progressive multiple sclerosis.Clinical characteristics of progressive relapsing multiple sclerosis.Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.
P2860
Q22242023-54A43089-A966-41F9-8301-A5A9D13C83C7Q26783585-650DA30F-E6EB-4932-BD17-F83F2C9BE331Q26849274-13EFA8ED-5530-46B2-BEB1-D00A350A52E7Q31160866-1655EB57-49A7-4BE1-A358-5493BAA0F611Q33219635-80C8431A-A940-4FCB-B2F3-24A1E87BFDFEQ33589656-DD302C63-7B76-4E1E-A823-1ED41DC0E15BQ33590146-77978249-812C-4D89-B06F-2F5AB3597722Q33591702-8D7FCCE3-050E-46C3-929B-4D3473FE23F7Q33628316-0B6630E3-6990-4ADC-9E46-B95494F2432BQ33643239-3B9B6445-8965-4AF9-A847-EFDC34EABD13Q33684592-3AE7F309-9E5E-468E-88E0-27D26C158631Q33703202-B0A8BE98-1AC9-4A22-9299-739230A1F499Q33719214-36914CB6-8B9A-4202-A764-A3212847DF65Q33733079-4A7CDB10-7094-4D9A-91D6-873C4EEC73EFQ33733828-A9F7C873-BFB3-4D09-8B6B-0A572EB5CFB7Q33733925-A30F2525-1CFE-4C31-9325-8128A8107D54Q33734727-EE960F9E-87D6-4ADF-B43D-F84A29BD8971Q33834066-15D55633-E505-41E1-977D-79E807319E49Q33944200-D706E695-436D-4EBD-96CF-417A47E4D507Q34237823-4415C551-A247-4843-ACE9-904715CC957AQ34295012-B1F59322-E218-48E7-AFDA-346AC282D348Q34304182-FDD6460E-7380-4F7F-BE45-D8275653F9D8Q34468304-79557BA1-1E3E-48E8-959B-66CDCA39AEF8Q34478828-A32FF98C-8B03-4278-AB84-076A2DDCF368Q34997377-90C78CDF-8351-42AB-8A59-FDABFBAAEDCCQ35106567-EC383A11-37F3-44A7-8568-282AC3A2512BQ35123719-E10B9A6F-AAFA-4F1B-9620-1B5876F933AFQ35168285-0D88FA92-6BB0-4878-BDA9-33D07F11A507Q35230950-643A94F7-4320-4971-A53E-70C697BFFC3DQ35450216-7F55B54E-CA5C-4408-A28F-33CB987C956AQ35452477-377F16D0-19FC-49BD-91D4-178B5FA42837Q35453326-B098B588-06EB-4830-B75B-F73D7BB7761FQ35455705-61A0B8D9-0C34-4553-BB95-9EA368B5222AQ35465911-4D88C417-351A-4387-851D-C7C286B555D2Q35470638-49D68F3C-6759-4C61-B5AB-AFB0EC17A709Q35545150-4CB8BD1F-A4D2-4E51-BB58-E1FACC4A003DQ35604215-207741EF-0A2F-4112-BCF5-DD8527984131Q35818165-8A1E5E2F-17B1-415C-8364-1B89CF124FE0Q35870214-084235E7-8D42-4DC0-8E92-21F08E7F1288Q36005655-3EA92AAD-B56D-489F-8AC1-2B36F40F7F9E
P2860
Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Course and prognosis of multip ...... ta processing of 349 patients.
@ast
Course and prognosis of multip ...... ta processing of 349 patients.
@en
type
label
Course and prognosis of multip ...... ta processing of 349 patients.
@ast
Course and prognosis of multip ...... ta processing of 349 patients.
@en
prefLabel
Course and prognosis of multip ...... ta processing of 349 patients.
@ast
Course and prognosis of multip ...... ta processing of 349 patients.
@en
P2093
P356
P1433
P1476
Course and prognosis of multip ...... ta processing of 349 patients.
@en
P2093
P304
P356
10.1093/BRAIN/103.2.281
P407
P577
1980-06-01T00:00:00Z